This is a page that curates AI-related papers published worldwide. All content here is summarized using Google Gemini and operated on a non-profit basis. Copyright for each paper belongs to the authors and their institutions; please make sure to credit the source when sharing.
This paper emphasizes the importance of utilizing multimodal data in ophthalmic disease diagnosis, and addresses the challenges posed by the lack of multimodal data and data privacy issues in real-world medical settings. In terms of Limitations of existing deep learning methods, we point out the difficulties in extracting unique features due to redundant latent space representations caused by redundant information in complex modalities and redundant representations across modalities. To address these issues, we propose Essence-Point and Disentangle Representation Learning (EDRL) strategies. EDRL is an end-to-end framework that integrates a self-distillation mechanism to enhance feature selection and disentanglement, enabling more robust multimodal learning. The Essence-Point Representation Learning module selects discriminative features that enhance disease grade prediction performance, and the Disentangled Representation Learning module separates multimodal data into modality common and unique representations to reduce feature entanglement and improve the robustness and interpretability of ophthalmic disease diagnosis. Experimental results on multi-modal ophthalmic datasets demonstrate that the EDRL strategy significantly outperforms existing state-of-the-art methods.
Takeaways, Limitations
•
Takeaways:
◦
A novel deep learning strategy (EDRL) is presented to address the problem of limited availability of multimodal data.
◦
Effective feature selection and disentanglement via magnetic distillation mechanism
◦
Improving the accuracy and interpretability of ophthalmic disease diagnosis
◦
Improved performance compared to existing state-of-the-art methods
•
Limitations:
◦
Further research is needed on the generalization performance of the proposed method.
◦
Additional experiments are needed on various ophthalmic diseases and datasets.
◦
Additional validation needed for application in real clinical settings